Literature DB >> 26856882

Erectile dysfunction: Vardenafil in men with T2DM.

Clemens Thoma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26856882     DOI： 10.1038/nrurol.2016.30

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  Six months of daily treatment with vardenafil improves parameters of endothelial inflammation and of hypogonadism in male patients with type 2 diabetes and erectile dysfunction: a randomized, double-blind, prospective trial.

Authors:  Daniele Santi; Antonio R M Granata; Alessandro Guidi; Elisa Pignatti; Tommaso Trenti; Laura Roli; Roberto Bozic; Stefano Zaza; Chiara Pacchioni; Stefania Romano; Jerzy Roch Nofer; Vincenzo Rochira; Cesare Carani; Manuela Simoni
Journal:  Eur J Endocrinol       Date:  2016-01-20       Impact factor: 6.664
  1 in total
  2 in total

1.  FOXM1 evokes 5-fluorouracil resistance in colorectal cancer depending on ABCC10.

Authors:  Tao Xie; Jian Geng; Ye Wang; Liya Wang; Mengxi Huang; Jing Chen; Kai Zhang; Lijun Xue; Xiaobei Liu; Xiaobei Mao; Yanan Chen; Qian Wang; Tingting Dai; Lili Ren; Hongju Yu; Rui Wang; Longbang Chen; Cheng Chen; Xiaoyuan Chu
Journal:  Oncotarget       Date:  2017-01-31

2.  Identification of Pathologic Grading-Related Genes Associated with Kidney Renal Clear Cell Carcinoma.

Authors:  Weijian Xiong; Jin Zhong; Ying Li; Xunjia Li; Lili Wu; Ling Zhang
Journal:  J Immunol Res       Date:  2022-07-30       Impact factor: 4.493
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.